Evidence map›Paper›PMID 23358110›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2013

Effect of the GPI anchor of human Thy-1 on antibody recognition and function.

John E Bradley, Joy M Chan, James S Hagood

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Major Surface Antigens in ZoonoticPathogens (Basel, Switzerland) · 2022
    Review
  5. Observational
  6. Review
  7. Thy-1 as an Integrator of Diverse Extracellular Signals.Frontiers in cell and developmental biology · 2019
    Review
  8. Article
  9. Thy-1, a Pathfinder Protein for the Post-genomic Era.Frontiers in cell and developmental biology · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution.Laboratory investigation; a journal of technical methods and pathology · 2017
    Article
  15. Article
  16. Article
  17. Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

John E BradleyDepartment of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Joy M Chan
James S Hagood
University of California, San Diego · USUniversity of Alabama at Birmingham · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
Regulation of Fibroblast Phenotype in Lung FibrosisR01HL082818 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAGOOD, JAMES S. · 2007 to 2017
$3.7M
NHLBI NIH HHS R01 HL082818NHLBI NIH HHS R01HL082818NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI36214
6 · The paper itself

Abstract

Thymocyte differentiation antigen-1 (Thy-1) is a glycosylphosphatidylinositol (GPI)-linked cell surface glycoprotein expressed on numerous cell types, which regulates signals affecting cell adhesion, migration, differentiation, and survival. In addition, Thy-1 has been detected in the serum, cerebral spinal fluid, wound fluid from venous ulcers, synovial fluid from joints in rheumatoid arthritis, and, more recently, urine. We previously detected Thy-1 in the conditioned media of cytokine-stimulated lung fibroblasts, suggesting that Thy-1 shedding may be a response to cellular stress. Soluble and membrane-bound forms of Thy-1 from in vivo sources have been shown to be identical in size when deglycosylated, suggesting that soluble Thy-1 is separated from the diacyl glycerol portion of its GPI anchor by hydrolysis within the GPI moiety. For Thy-1- and other GPI-anchored proteins, delipidation induces a stable change in conformation that manifests itself in a change in antibody affinity for soluble forms. Using epitope-tagged recombinant soluble Thy-1, we report that widely available monoclonal antibodies to human Thy-1 are unable to detect soluble Thy-1 by immunoblotting. We re-evaluated the Thy-1 that we previously reported in the conditioned media of normal human lung fibroblasts and found it to be entirely insoluble. These findings suggest that most Thy-1 reported in body fluids retains its GPI anchor and may be associated with membrane fragments or vesicles. This phenomenon should be considered in the generation of antibodies and controls for Thy-1 bioassays. Furthermore, the changes in Thy-1 conformation with delipidation, beyond affecting antibody affinity, likely affect the ligand affinity and biological function of soluble vs released membrane-associated forms.

Indexed as

AnimalsAntibodies, MonoclonalAntibody SpecificityBlotting, WesternCell LineCentrifugationFlow CytometryGlycosylphosphatidylinositolsHumansOctoxynolPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePolyethylene GlycolsRatsRecombinant ProteinsSignal TransductionThy-1 AntigensAntibodies, MonoclonalGlycosylphosphatidylinositolsNonidet P-40OctoxynolPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePolyethylene GlycolsRecombinant ProteinsThy-1 Antigens

Identifiers

PMID23358110
PMCPMC5662197
OpenAlexW2070935129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.